Introduction: Fibroblasts are central to a variety of homeostatic events such as wound healing and tissue regeneration. However, their pathologic activation is thought to play roles in a variety of diseases not only limited to fibrosis, foreign body reaction, scleroderma but also cancer metastasis. Biophysical properties of the extracellular matrix (ECM) deposited by an activated fibroblast determine whether there is a pro-regenerative or scarring response. Compared to aged fibroblasts, embryonic fibroblasts were shown to deposit a pro-regenerative ECM characterized by early hyaluronic acid (HA) deposition and increased levels of pro-regenerative collagens such as type III collagen. Since HA is also a regulator of collagen organization, we propose that early accumulation of HA by fibroblasts can facilitate pro-regenerative matrix formation. Given that the molecular weights of HA present in pro-regenerative matrix are higher than synthetic HA, we strategize attracting HA synthesized by fibroblasts. In this study, we used a synthetic peptide sequence known to have affinity to HA as a strategy to instruct fibroblasts to retain HA on the surface. We hypothesized that hyaluronic acid binding peptide (HABP) may instruct fibroblast endogenous HA deposition onto functionalized surfaces. Methods: We functionalized silica glass surfaces with HABP using aminoorganosilane mediated chemisorption and screened primary human dermal fibroblasts (HDFs) for cell morphology, cytoskeletal arrangement, and alpha-smooth muscle actin (α-SMA) expression. Results: Our results show HABP treated surfaces retain higher levels of HA on silica glass compared to control surfaces on fibroblast-derived matrices. Analysis of α-SMA shows increased α-SMA expression on hDFs and increased stress fiber formation. HABP treated surfaces were found to have reduced α-SMA expression. The physical features of collagen fibers deposited by fibroblasts were also organized differently in the presence of HABP. Conclusion: Due to their ability to diminish fibroblast contractility and promote regenerative ECM production, HABPs are a potentially viable strategy to instruct pro-regenerative fibroblasts and can be used therapeutically to treat fibrotic diseases.

1.
Bainbridge
P
.
Wound healing and the role of fibroblasts
.
J Wound Care
.
2013
;
22
(
8
):
407
12
.
2.
Darby
IA
,
Hewitson
TD
.
Fibroblast differentiation in wound healing and fibrosis
.
Int Rev Cytol
.
2007
;
257
:
143
79
.
3.
Xing
F
,
Saidou
J
,
Watabe
K
.
Cancer associated fibroblasts (CAFs) in tumor microenvironment
.
Front Biosci
.
2010
;
15
(
1
):
166
79
.
4.
Denu
RA
,
Nemcek
S
,
Bloom
DD
,
Goodrich
AD
,
Kim
J
,
Mosher
DF
, et al
.
Fibroblasts and mesenchymal stromal/stem cells are phenotypically indistinguishable
.
Acta Haematol
.
2016
;
136
(
2
):
85
97
.
5.
Blake
B
,
Ozdemir
T
.
[Developing fibrous biomaterials to modulate epithelial to mesenchymal transition]
.
Cells Tissues Organs
.
2023
;
212
(
5
):
416
38
.
6.
Krafts
KP
.
Tissue repair: the hidden drama
.
Organogenesis
.
2010
;
6
(
4
):
225
33
.
7.
Kreus
M
,
Lehtonen
S
,
Skarp
S
,
Kaarteenaho
R
.
Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma
.
PLoS One
.
2021
;
16
(
4
):
e0250109
.
8.
Takahashi
K
,
Okita
K
,
Nakagawa
M
,
Yamanaka
S
.
Induction of pluripotent stem cells from fibroblast cultures
.
Nat Protoc
.
2007
;
2
(
12
):
3081
9
.
9.
Lu
H
,
Hoshiba
T
,
Kawazoe
N
,
Koda
I
,
Song
M
,
Chen
G
.
Cultured cell-derived extracellular matrix scaffolds for tissue engineering
.
Biomaterials
.
2011
;
32
(
36
):
9658
66
.
10.
Ural
IH
,
Alptekin
K
,
Ketenci
A
,
Solakoglu
S
,
Alpak
H
,
Özyalçın
S
.
Fibroblast transplantation results to the degenerated rabbit lumbar intervertebral discs
.
Open Orthop J
.
2017
;
11
:
404
16
.
11.
Goyer
B
,
Larouche
D
,
Kim
DH
,
Veillette
N
,
Pruneau
V
,
Bernier
V
, et al
.
Immune tolerance of tissue-engineered skin produced with allogeneic or xenogeneic fibroblasts and syngeneic keratinocytes grafted on mice
.
Acta Biomater
.
2019
;
90
:
192
204
.
12.
Haydont
V
,
Bernard
BA
,
Fortunel
NO
.
Age-related evolutions of the dermis: clinical signs, fibroblast and extracellular matrix dynamics
.
Mech Ageing Dev
.
2019
;
177
:
150
6
.
13.
Schultz
GS
,
Davidson
JM
,
Kirsner
RS
,
Bornstein
P
,
Herman
IM
.
Dynamic reciprocity in the wound microenvironment
.
Wound Repair Regen
.
2011
;
19
(
2
):
134
48
.
14.
Huffer
A
,
Ozdemir
T
.
Substrate stiffness regulates type II diabetic fibroblast phenotype and metabolic activity
.
Biochem Biophys Res Commun
.
2024
;
709
:
149833
.
15.
Cherng
S
,
Young
J
,
Ma
H
.
Alpha-smooth muscle actin (α-SMA)
.
J Am Sci
.
2008
;
4
(
4
):
7
9
.
16.
Hinz
B
,
Celetta
G
,
Tomasek
JJ
,
Gabbiani
G
,
Chaponnier
C
.
Alpha-smooth muscle actin expression upregulates fibroblast contractile activity
.
Mol Biol Cell
.
2001
;
12
(
9
):
2730
41
.
17.
Chen
J
,
Li
H
,
SundarRaj
N
,
Wang
JHC
.
Alpha‐smooth muscle actin expression enhances cell traction force
.
Cell Motil Cytoskeleton
.
2007
;
64
(
4
):
248
57
.
18.
Xue
M
,
Jackson
CJ
.
Extracellular matrix reorganization during wound healing and its impact on abnormal scarring
.
Adv Wound Care
.
2015
;
4
(
3
):
119
36
.
19.
Olczyk
P
,
Mencner
Ł
,
Komosinska-Vassev
K
.
The role of the extracellular matrix components in cutaneous wound healing
.
BioMed Res Int
.
2014
;
2014
(
1
):
747584
.
20.
Olutoye
OO
,
Cohen
IK
.
Fetal wound healing: an overview
.
Wound Repair Regen
.
1996
;
4
(
1
):
66
74
.
21.
Dicker
KT
,
Gurski
LA
,
Pradhan-Bhatt
S
,
Witt
RL
,
Farach-Carson
MC
,
Jia
X
.
Hyaluronan: a simple polysaccharide with diverse biological functions
.
Acta Biomater
.
2014
;
10
(
4
):
1558
70
.
22.
Fraser
JRE
,
Laurent
TC
,
Laurent
U
.
Hyaluronan: its nature, distribution, functions and turnover
.
J Intern Med
.
1997
;
242
(
1
):
27
33
.
23.
Turley
EA
.
Hyaluronan-binding proteins and receptors
.
Adv Drug Deliv Rev
.
1991
;
7
(
2
):
257
64
.
24.
Day
AJ
,
de la Motte
CA
.
Hyaluronan cross-linking: a protective mechanism in inflammation
.
Trends Immunol
.
2005
;
26
(
12
):
637
43
.
25.
Day
AJ
,
Prestwich
GD
.
Hyaluronan-binding proteins: tying up the giant
.
J Biol Chem
.
2002
;
277
(
7
):
4585
8
.
26.
Faust
HJ
,
Sommerfeld
SD
,
Rathod
S
,
Rittenbach
A
,
Ray Banerjee
S
,
Tsui
BMW
, et al
.
A hyaluronic acid binding peptide-polymer system for treating osteoarthritis
.
Biomaterials
.
2018
;
183
:
93
101
.
27.
Zaleski
KJ
,
Kolodka
T
,
Cywes-Bentley
C
,
McLoughlin
RM
,
Delaney
ML
,
Charlton
BT
, et al
.
Hyaluronic acid binding peptides prevent experimental staphylococcal wound infection
.
Antimicrob Agents Chemother
.
2006
;
50
(
11
):
3856
60
.
28.
Yan
LH
,
Zhang
Y
,
Hu
H
,
Zhang
C
,
Wang
Y
,
Xu
X
, et al
.
Enhanced transdermal absorption of hyaluronic acid via fusion with pep‐1 and a hyaluronic acid binding peptide
.
Macromol Biosci
.
2023
;
23
(
3
):
2200173
.
29.
Singh
A
,
Corvelli
M
,
Unterman
SA
,
Wepasnick
KA
,
McDonnell
P
,
Elisseeff
JH
.
Enhanced lubrication on tissue and biomaterial surfaces through peptide-mediated binding of hyaluronic acid
.
Nat Mater
.
2014
;
13
(
10
):
988
95
.
30.
Huffer
A
,
Mao
M
,
Ballard
K
,
Ozdemir
T
.
Biomimetic hyaluronan binding biomaterials to capture the complex regulation of hyaluronan in tissue development and function
.
Biomimetics
.
2024
;
9
(
8
):
499
.
31.
Beamson
G
,
Briggs
DR
.
The XPS of polymers database
.
2000
.
32.
Luzak
B
,
Siarkiewicz
P
,
Boncler
M
.
An evaluation of a new high-sensitivity PrestoBlue assay for measuring cell viability and drug cytotoxicity using EA. hy926 endothelial cells
.
Toxicol Vitro
.
2022
;
83
:
105407
.
33.
Hinz
B
.
Myofibroblasts
.
Exp Eye Res
.
2016
;
142
:
56
70
.
34.
Hinz
B
.
Formation and function of the myofibroblast during tissue repair
.
J Invest Dermatol
.
2007
;
127
(
3
):
526
37
.
35.
Mast
BA
,
Flood
LC
,
Haynes
JH
,
DePalma
RL
,
Cohen
IK
,
Diegelmann
RF
, et al
.
Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implications for healing by regeneration
.
Matrix
.
1991
;
11
(
1
):
63
8
.
36.
Doillon
CJ
.
Collagen deposition during wound repair
.
Scanning Electron Microscopy
.
1985
;
1985
(
2
):
39
.
37.
Hillsley
A
,
Santoso
MS
,
Engels
SM
,
Halwachs
KN
,
Contreras
LM
,
Rosales
AM
.
A strategy to quantify myofibroblast activation on a continuous spectrum
.
Sci Rep
.
2022
;
12
(
1
):
12239
.
You do not currently have access to this content.